Figures & data
Figure 1 MRI scans. (A) and (C) show the cervical lesion and the left pelvic wall metastatic lymph node before treatment, respectively; (B) and (D) show the cervix and the left pelvic wall lymph node after treatment, respectively.
![Figure 1 MRI scans. (A) and (C) show the cervical lesion and the left pelvic wall metastatic lymph node before treatment, respectively; (B) and (D) show the cervix and the left pelvic wall lymph node after treatment, respectively.](/cms/asset/f8f97e7e-1c3e-4432-b59d-498d8bc60495/djwh_a_12150300_f0001_c.jpg)
Figure 4 (A) (HE staining, ×10) and (B) (HE staining, ×5) are the first postoperative images revealing a Schneiderian papilloma; (C) (HE staining, ×10) and (D) (HE staining, ×20) are the second postoperative images revealing a Schneiderian papilloma that exhibited papilloma-like hyperplasia.
![Figure 4 (A) (HE staining, ×10) and (B) (HE staining, ×5) are the first postoperative images revealing a Schneiderian papilloma; (C) (HE staining, ×10) and (D) (HE staining, ×20) are the second postoperative images revealing a Schneiderian papilloma that exhibited papilloma-like hyperplasia.](/cms/asset/60606caa-fa69-411d-8725-c67bb93371cc/djwh_a_12150300_f0004_c.jpg)
Figure 5 The changes, treatment, and timeline of SCCA assessment throughout the course of the disease. The quantitative results for SCCA shown in red are higher than normal (SCCA normal range 0–1.8ng/ mL). The patient underwent sinus tumor resection on October 12, 2020, and an enlarged sinus tumor resection on June 18, 2021.
![Figure 5 The changes, treatment, and timeline of SCCA assessment throughout the course of the disease. The quantitative results for SCCA shown in red are higher than normal (SCCA normal range 0–1.8ng/ mL). The patient underwent sinus tumor resection on October 12, 2020, and an enlarged sinus tumor resection on June 18, 2021.](/cms/asset/5b8d99e5-1c2c-4dad-b33d-bd7d6f4dc23a/djwh_a_12150300_f0005_c.jpg)